mRNA-1647 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-08-01 in 1mo
ESTIMATED |
READOUT
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytome
Phase 2 · Cytomegalovirus Infection |
ModernaTX, Inc. | mRNA-1647 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|